[1] Terrault NA, Lok ASF, Mcmahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology, 2018,67: 1560-1599.
[2] Indolfi G, Azzari C, Resti M. Perinatal transmission of hepatitis C virus. J Pediatr, 2013,163: 1549-1552 e1541.
[3] Panel A-IHG. Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis, 2018,67: 1477-1492.
[4] Abu-Hayyeh S, Ovadia C, Lieu T, et al. Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum. Hepatology, 2016,63: 1287-1298.
[5] Kremer AE, Bolier R, Dixon PH, et al. Autotaxin activity has a high accuracy to diagnose intrahepatic cholestasis of pregnancy. J Hepatol, 2015,62: 897-904.
[6] Dixon PH, Sambrotta M, Chambers J, et al. An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy. Sci Rep, 2017,7: 11823.
[7] Chappell LC, Bell JL, Smith A, et al. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet, 2019,394: 849-860.
[8] Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol, 2020,73: 202-209.
[9] Brumbaugh DE, Tearse P, Cree-Green M, et al. Intrahepatic fat is increased in the neonatal offspring of obese women with gestational diabetes. J Pediatr, 2013,162: 930-936 e931.
[10] Patel KR, White FV, Deutsch GH. Hepatic steatosis is prevalent in stillborns delivered to women with diabetes mellitus. J Pediatr Gastroenterol Nutr, 2015,60: 152-158.
[11] Ayonrinde OT, Adams LA, Mori TA, et al. Sex differences between parental pregnancy characteristics and nonalcoholic fatty liver disease in adolescents. Hepatology, 2018,67: 108-122.
[12] Patel S, Lawlor DA, Callaway M, et al. Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease. BMC Pediatr, 2016,16: 47.
[13] Jonscher KR, Stewart MS, Alfonso-Garcia A, et al. Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice. FASEB J, 2017,31: 1434-1448.
[14] Squires RH, Jr., Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr, 2006,148: 652-658.
[15] Sheflin-Findling S, Annunziato RA, Chu J, et al. Liver transplantation for neonatal hemochromatosis: analysis of the UNOS database. Pediatr Transplant, 2015,19: 164-169.
[16] Zozaya Nieto C, Fernandez Caamano B, Munoz Bartolo G, et al. Presenting Features and Prognosis of Ischemic and Nonischemic Neonatal Liver Failure. J Pediatr Gastroenterol Nutr, 2017,64: 754-759.
[17] Nicastro E, D'antiga L. Next generation sequencing in pediatric hepatology and liver transplantation. Liver Transpl, 2018,24: 282-293.
[18] Stalke A, Skawran B, Auber B, et al. Diagnosis of monogenic liver diseases in childhood by next-generation sequencing. Clin Genet, 2018,93: 665-670.
[19] Chen HL, Li HY, Wu JF, et al. Panel-Based Next-Generation Sequencing for the Diagnosis of Cholestatic Genetic Liver Diseases: Clinical Utility and Challenges. J Pediatr, 2019,205: 153-159 e156.
[20] 林伟霞, 郑琪琪, 郭丽, 等. 首例非白人婴儿肝衰竭综合征1型患儿临床特点和分子诊断研究. 中国当代儿科杂志, 2017, 19: 913-920.
[21] 刘攀, 刘小乖, 彭晓康, 等. 婴儿肝衰竭综合征1型1例病例报告. 中国循证儿科杂志, 2020, 15: 76-80.
[22] Rana A, Kueht ML, Nicholas SK, et al. Pediatric Liver Transplantation Across the ABO Blood Group Barrier: Is It an Obstacle in the Modern Era? J Am Coll Surg, 2016,222: 681-689.
[23] Zhang R, Zhu ZJ, Sun LY, et al. Outcomes of Liver Transplantation Using Pediatric Deceased Donor Livers: A Single-Center Analysis of 102 Donors. Chin Med J (Engl), 2018,131: 677-683.
[24] 刘源, 夏强, 张建军, 等. 亲体肝移植治疗新生儿肝内胆汁淤积型希特林缺乏症1例. 实用器官移植电子杂志, 2018, 6: 461-463. |
